SCICLONE PHARMACEUTICALS INC (SCLN) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 542 transactions totaling $95.0M, demonstrating a bearish sentiment with -$86.5M in net insider flow. The most recent transaction on Oct 13, 2017 involved a transaction of 144,158 shares valued at $1.6M.
No significant insider buying has been recorded for SCLN in the recent period.
No significant insider selling has been recorded for SCLN in the recent period.
Based on recent SEC filings, insider sentiment for SCLN is bearish with an Insider Alignment Score of 4/100 and a net flow of -$86.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at SCICLONE PHARMACEUTICALS INC (SCLN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading SCLN stock, having executed 542 transactions in the past 90 days. The most active insider is Paolo Cavazza (Executive), who has made 50 transactions totaling $40.5M.
Get notified when executives and directors at SCLN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 13, 2017 | Wai-shun Cheung Wilson | Executive | Disposition | 144,158 | $11.18 | $1.6M | Large |
| Oct 13, 2017 | Wai-shun Cheung Wilson | Executive | Award | 75,000 | $N/A | $0 | |
| Oct 13, 2017 | Wai-shun Cheung Wilson | Executive | Option Exercise | 52,000 | $N/A | $0 | |
| Oct 13, 2017 | J. Hawkins Richard | Executive | Disposition | 24,363 | $11.18 | $272.4K | |
| Oct 13, 2017 | Xie Lan | Executive | Option Exercise | 8,000 | $N/A | $0 | |
| Oct 13, 2017 | Xie Lan | Executive | Disposition | 8,000 | $11.18 | $89.4K | |
| Oct 13, 2017 | Chern Carey | Executive | Disposition | 20,708 | $11.18 | $231.5K | |
| Oct 13, 2017 | Chern Carey | Executive | Payment | 11,274 | $11.18 | $126.0K | |
| Oct 13, 2017 | Chern Carey | Executive | Option Exercise | 30,000 | $N/A | $0 | |
| Oct 13, 2017 | T. Chang Nancy | Executive | Disposition | 70,000 | $11.18 | $782.6K | Large |
| Oct 13, 2017 | Zhao Hong | Executive | Award | 75,000 | $N/A | $0 | |
| Oct 13, 2017 | Zhao Hong | Executive | Disposition | 127,000 | $11.18 | $1.4M | Large |
| Oct 13, 2017 | Zhao Hong | Executive | Option Exercise | 52,000 | $N/A | $0 | |
| Oct 13, 2017 | Anthony Low Raymond | Executive | Option Exercise | 11,250 | $N/A | $0 | |
| Oct 13, 2017 | Anthony Low Raymond | Executive | Disposition | 37,748 | $11.18 | $422.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 160 | $90.8M | 71.0% |
Disposition(D) | 13 | $15.4M | 12.1% |
Exercise(M) | 184 | $8.0M | 6.3% |
Payment(F) | 20 | $7.1M | 5.6% |
Purchase(P) | 152 | $4.2M | 3.3% |
Exercise (Options)(X) | 9 | $2.3M | 1.8% |
Award(A) | 3 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at SCICLONE PHARMACEUTICALS INC has increased, with 25 insiders executing 542 transactions across all time. Total sales of $90.8M significantly outpace purchases of $4.2M, resulting in a net outflow of $86.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.